Explore our latest news and market updates.
Nick Puncer, Portfolio Manager and member of Bahl & Gaynor’s Investment Committee, shares a mid-quarter update…
Bahl & Gaynor announces that after strong investor traction since launch in August 2021, the firm’s smig® – Small/Mid Cap Income Growth…
Eli Lilly’s experimental pill worked as well as blockbuster drug Ozempic to lower weight and blood sugar in a trial of…
You are now leaving the Bahl & Gaynor main website and entering into the Active ETFs website. By continuing to this link, we are not making any representation, warranty, or endorsement about the website and we are not providing you with investment advice or offering securities for sale to you.
